Home › Funds › M&G Plc › DGX

M&G Plc position in DGX

QUEST DIAGNOSTICS INC · Health Care

M&G Plc reported holding 770,102 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$179.4M, representing 0.92% of its reported portfolio and ranking #33 among its reported holdings. M&G Plc has disclosed DGX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)770.10K sh
Reported value held$179.43M
Portfolio Weight0.92%
First reportedQ1 2024
Last changeReduce
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How M&G Plc's DGX position evolved

M&G Plc first disclosed a stake in DGX in Q1 2024 at 349,116 shares (US$46.4M). The position peaked in Q3 2025 at 1,090,377 shares, worth US$208.3M. Across 11 filings, M&G Plc increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 770,102 shares valued at US$179.4M — a reduction of -25,548 shares quarter over quarter.. Notable position changes include a 257% increase in Q2 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 349.12K $46.43M New
Q2 2024 334.37K $45.81M Reduce
Q3 2024 332.00K $51.46M Reduce
Q4 2024 320.92K $48.46M Reduce
Q1 2025 300.90K $50.85M Reduce
Q2 2025 1.07M $193.09M Add
Q3 2025 1.09M $208.26M Add
Q4 2025 945.05K $164.44M Reduce
Q1 2026 805.34K $157.85M Reduce
Q2 2026 795.65K $168.68M Reduce
Q3 2026 770.10K $179.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 30 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has M&G Plc held DGX?

M&G Plc has disclosed DGX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is M&G Plc's current position in DGX?

As of Q3 2026, M&G Plc holds 770.10K shares of DGX (QUEST DIAGNOSTICS INC), valued at $179.43M, representing 0.92% of its reported portfolio and ranking #33.

Has M&G Plc been buying or selling DGX?

In the latest 13F filing (Q3 2026), M&G Plc reduced its position in DGX. The position peaked in Q3 2025 at 1.09M shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.